Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-22

Clinical Trial Update: A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for AS1986NS describing a single-arm, blinded fluorescent PSMA histopathology study in prostate cancer across Phase 1 and Phase 2; the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AS1986NS

Snippet

Sponsor: Antelope Surgical Solutions, Inc | Conditions: Prostate Cancer, Prostate Cancer (Adenocarcinoma) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING